Massachusetts Financial Services’s Revolution Medicines RVMD Stock Holding History

Massachusetts Financial Services’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377M	Buy	+2,012,317	New	+$294M	0.12%	178

Other funds holding RVMD

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Massachusetts Financial Services's RVMD Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,012,317 shares worth $377M. The stake represents 0.12% of the portfolio and ranks #178 among its holdings.

211 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Massachusetts Financial Services held 2,012,317 shares of Revolution Medicines worth $377M as of Q2 2026.
Revolution Medicines was a new Massachusetts Financial Services position in Q2 2026.
Revolution Medicines made up 0.12% of Massachusetts Financial Services's portfolio in Q2 2026, its #178 holding.
211 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.